ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Capitalizing on a gene therapy boom, Avrobio locks in $60M – MedCity News

Continue reading

2018-02-05 Michael Zand NEWS

Global Immuno-oncology Therapeutics Market 2018 – Adoptive T-cell Therapies Forecast to 2022 … – Business Wire (press release)

Global Immuno-oncology Therapeutics Market 2018 – Adoptive T-cell Therapies Forecast to 2022 …Business Wire (press release)Chimeric antigen receptor (CAR) T-cell therapy will change the way cancer is being treated. In the second half of 2017, the fir… Continue reading

2018-02-05 Michael Zand NEWS

First cow embryonic stem cells could lead to healthier, more productive livestock – Science Magazine

Science MagazineFirst cow embryonic stem cells could lead to healthier, more productive livestockScience MagazineAfter decades of effort, scientists have finally managed to derive embryonic stem (ES) cells from cows and keep them in their primitive sta… Continue reading

2018-02-05 Michael Zand NEWS

Global Immuno-oncology Therapeutics Market 2018: Adoptive T-cell Therapies Forecast to 2022 – The Next Generation … – Markets Insider

Global Immuno-oncology Therapeutics Market 2018: Adoptive T-cell Therapies Forecast to 2022 – The Next Generation …Markets InsiderChimeric antigen receptor (CAR) T-cell therapy will change the way cancer is being treated. In the second half of 2017, … Continue reading

2018-02-05 Michael Zand NEWS

Global Immuno-oncology Therapeutics Market 2018: Adoptive T-cell Therapies Forecast to 2022 – The Next Generation … – PR Newswire (press release)

Global Immuno-oncology Therapeutics Market 2018: Adoptive T-cell Therapies Forecast to 2022 – The Next Generation …PR Newswire (press release)Chimeric antigen receptor (CAR) T-cell therapy will change the way cancer is being treated. In the second ha… Continue reading

2018-02-05 Michael Zand NEWS

Former Novartis chief Joseph Jimenez discusses breakthroughs in gene therapy, future of CRISPR in medicine – Genetic Literacy Project


MedCity News

Capitalizing on a gene therapy boom, Avrobio locks in $60M
MedCity News
Cambridge, Massachusetts-based Avrobio has closed an oversubscribed $60 million Series B financing round to further its ex vivo lentiviral platform for the treatment of lysosomal storage disorders. It’s one more sign that after decades of ups and downs …

Continue reading

2018-02-05 Michael Zand NEWS

Scientists target glioma cancer stem cells, which could improve patient survival – Medical Xpress

Medical XpressScientists target glioma cancer stem cells, which could improve patient survivalMedical XpressMultiple studies suggest that these cancer stem cells resist therapy and give rise to recurrences. "To put it simply, if you eliminate most… Continue reading

2018-02-05 Michael Zand NEWS

MIT IQ Aims to Advance Human, Machine Intelligence Research – Geek

MIT IQ Aims to Advance Human, Machine Intelligence ResearchGeekThe initiative, known as MIT IQ, aims to “discover the foundations of human intelligence and drive the development of technological tools that can positively influence virtually every aspec… Continue reading

2018-02-05 Michael Zand NEWS
  • 1
  • …
  • 572
  • 573
  • 574
  • 575
  • 576
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Genetic Literacy Project

Former Novartis chief Joseph Jimenez discusses breakthroughs in gene therapy, future of CRISPR in medicine
Genetic Literacy Project
Editor’s Note: Novartis CEO Joseph Jimenez retired in January after eight years in the top job at one of the world’s top pharmaceutical companies. During his tenure, the company helped lead a movement that put gene therapies on the map. Scientific …